A crosstalk between TGF-β/Smad3 and Wnt/β-catenin pathways promotes vascular smooth muscle cell proliferation.
暂无分享,去创建一个
Xudong Shi | Sarah R. Franco | Mirnal A. Chaudhary | Joshua Zent | Katie Wang | Lian‐Wang Guo | K. C. Kent | Daniel M DiRenzo
[1] Z. Yao,et al. Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cells , 2015, Oncotarget.
[2] Kazunari Hattori,et al. Wnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and -independent mechanisms, respectively , 2015, Scientific Reports.
[3] W. Zhong,et al. Serum and glucocorticoid-regulated kinase 1 promotes vascular smooth muscle cell proliferation via regulation of β-catenin dynamics. , 2014, Cellular signalling.
[4] Jason L. Johnson,et al. Wnt5a-Induced Wnt1-Inducible Secreted Protein-1 Suppresses Vascular Smooth Muscle Cell Apoptosis Induced by Oxidative Stress , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[5] K. Kent,et al. TGF-β/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A , 2014, Cell Death and Disease.
[6] C. Landen,et al. Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer. , 2014, Gynecologic oncology.
[7] Xudong Shi,et al. TGF-β/Smad3 Stimulates Stem Cell/Developmental Gene Expression and Vascular Smooth Muscle Cell De-Differentiation , 2014, PloS one.
[8] M. Sonobe,et al. Intratumoral Wnt2B expression affects tumor proliferation and survival in malignant pleural mesothelioma patients. , 2012, Experimental and therapeutic medicine.
[9] G. Dressler,et al. Activation of Wnt11 by Transforming Growth Factor-β Drives Mesenchymal Gene Expression through Non-canonical Wnt Protein Signaling in Renal Epithelial Cells* , 2012, The Journal of Biological Chemistry.
[10] K. Kent,et al. Protein Kinase C-Delta Mediates Adventitial Cell Migration Through Regulation of Monocyte Chemoattractant Protein-1 Expression in a Rat Angioplasty Model , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[11] Hongyan Wang,et al. Silencing Wnt2B by siRNA Interference Inhibits Metastasis and Enhances Chemotherapy Sensitivity in Ovarian Cancer , 2012, International Journal of Gynecologic Cancer.
[12] C. Nguyên,et al. Interactions Between β-Catenin and Transforming Growth Factor-β Signaling Pathways Mediate Epithelial-Mesenchymal Transition and Are Dependent on the Transcriptional Co-activator cAMP-response Element-binding Protein (CREB)-binding Protein (CBP)* , 2012, The Journal of Biological Chemistry.
[13] Oliver Distler,et al. Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis , 2012, Nature Communications.
[14] R. Kypta,et al. Wnt11 in 2011 – the regulation and function of a non‐canonical Wnt , 2012, Acta physiologica.
[15] G. Piazza,et al. Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway , 2011, PloS one.
[16] Kevin Croce,et al. Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis. , 2011, JACC. Cardiovascular interventions.
[17] C. Garbe,et al. β-Catenin Signaling Increases during Melanoma Progression and Promotes Tumor Cell Survival and Chemoresistance , 2011, PloS one.
[18] Dong-Eun Kim,et al. Small molecule-based disruption of the Axin/β-catenin protein complex regulates mesenchymal stem cell differentiation , 2011, Cell Research.
[19] A. Swain,et al. Wnt4/&bgr;-Catenin Signaling Induces VSMC Proliferation and Is Associated With Intimal Thickening , 2011, Circulation research.
[20] H. Koga,et al. Noncanonical Wnt11 Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration , 2010, Molecular Cancer Research.
[21] X. Tan,et al. Smad3 Prevents β-Catenin Degradation and Facilitates β-Catenin Nuclear Translocation in Chondrocytes* , 2010, The Journal of Biological Chemistry.
[22] S. Hollenbeck,et al. Arterial gene transfer of the TGF-beta signalling protein Smad3 induces adaptive remodelling following angioplasty: a role for CTGF. , 2009, Cardiovascular research.
[23] Xi He,et al. Wnt/beta-catenin signaling: components, mechanisms, and diseases. , 2009, Developmental cell.
[24] H. Welch,et al. National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. , 2009, Journal of vascular surgery.
[25] S. Hollenbeck,et al. TGF-beta through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation. , 2009, American journal of physiology. Heart and circulatory physiology.
[26] K. Kent,et al. Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation. , 2009, Journal of vascular surgery.
[27] K. Plate,et al. Wnt/β-catenin signaling controls development of the blood–brain barrier , 2008, The Journal of cell biology.
[28] Ken Matsumoto,et al. Wnt9a secreted from the walls of hepatic sinusoids is essential for morphogenesis, proliferation, and glycogen accumulation of chick hepatic epithelium. , 2008, Developmental biology.
[29] H. Kerstjens,et al. GSK-3/beta-catenin signaling axis in airway smooth muscle: role in mitogenic signaling. , 2008, American journal of physiology. Lung cellular and molecular physiology.
[30] H. Okano,et al. β‐Catenin Signaling Promotes Proliferation of Progenitor Cells in the Adult Mouse Subventricular Zone , 2007, Stem cells.
[31] B. Cieply,et al. siRNA-Mediated β-Catenin Knockdown in Human Hepatoma Cells Results in Decreased Growth and Survival* , 2007 .
[32] B. Alman,et al. Beta‐catenin regulates wound size and mediates the effect of TGF‐beta in cutaneous healing , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] Evan J Ryer,et al. PKC&dgr; Is Necessary for Smad3 Expression and Transforming Growth Factor β–Induced Fibronectin Synthesis in Vascular Smooth Muscle Cells , 2006 .
[34] Xing Shen,et al. Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. , 2006, Genes & development.
[35] K. Park,et al. &bgr;-Catenin Overexpression Augments Angiogenesis and Skeletal Muscle Regeneration Through Dual Mechanism of Vascular Endothelial Growth Factor–Mediated Endothelial Cell Proliferation and Progenitor Cell Mobilization , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[36] W. Seeger,et al. Transforming Growth Factor-β-Dependent Growth Inhibition in Primary Vascular Smooth Muscle Cells Is p38-Dependent , 2005, Journal of Pharmacology and Experimental Therapeutics.
[37] Robert J Anderson,et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. , 2004, Journal of the American College of Cardiology.
[38] R. Nusse,et al. The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.
[39] A. Wynshaw-Boris,et al. The canonical Wnt pathway in early mammalian embryogenesis and stem cell maintenance/differentiation. , 2004, Current opinion in genetics & development.
[40] G. Owens,et al. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. , 2004, Physiological reviews.
[41] F. Marumo,et al. TGF-βbgr-activating kinase-1 inhibits cell cycle and expression of cyclin D1 and A in LLC-PK1 cells , 1999 .
[42] A. Miller,et al. Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes. , 1994, The Journal of clinical investigation.
[43] R. Stein,et al. Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.